{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:29:19Z","timestamp":1790224159960,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1038\/s41433-020-01287-y","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T20:03:42Z","timestamp":1606939422000},"page":"93-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond"],"prefix":"10.1038","volume":"35","author":[{"given":"Lydia","family":"Sauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra S.","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie K.","family":"Modersitzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4228-7666","authenticated-orcid":false,"given":"Paul S.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,2]]},"reference":[{"key":"1287_CR1","doi-asserted-by":"crossref","unstructured":"Lakowicz JR. Principles of fluorescence spectroscopy. New York: Springer; 2007.","DOI":"10.1007\/978-0-387-46312-4"},{"key":"1287_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s10439-011-0495-y","volume":"40","author":"L Marcu","year":"2012","unstructured":"Marcu L. Fluorescence lifetime techniques in medical applications. Ann Biomed Eng. 2012;40:304\u201331.","journal-title":"Ann Biomed Eng"},{"key":"1287_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1073\/pnas.89.4.1271","volume":"89","author":"JR Lakowicz","year":"1992","unstructured":"Lakowicz JR, Szmacinski H, Nowaczyk K, Johnson ML. Fluorescence lifetime imaging of free and protein-bound NADH. Proc Natl Acad Sci USA. 1992;89:1271\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1287_CR4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s00347-002-0656-3","volume":"99","author":"D Schweitzer","year":"2002","unstructured":"Schweitzer D, Kolb A, Hammer M, Anders R. Time-correlated measurement of autofluorescence. A method to detect metabolic changes in the fundus. Ophthalmologe. 2002;99:774\u20139.","journal-title":"Ophthalmologe"},{"key":"1287_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/jemt.20427","volume":"70","author":"D Schweitzer","year":"2007","unstructured":"Schweitzer D, Schenke S, Hammer M, Schweitzer F, Jentsch S, Birckner E, et al. Towards metabolic mapping of the human retina. Microsc Res Tech. 2007;70:410\u20139.","journal-title":"Microsc Res Tech"},{"key":"1287_CR6","unstructured":"Becker W. The bh TCSPC handbook. 6th ed. Berlin: Becker & Hickl GmbH; 2014."},{"key":"1287_CR7","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1167\/iovs.14-15335","volume":"56","author":"L Sauer","year":"2015","unstructured":"Sauer L, Schweitzer D, Ramm L, Augsten R, Hammer M, Peters S. Impact of macular pigment on fundus autofluorescence lifetimes. Investig Ophthalmol Vis Sci. 2015;56:4668\u201379.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1287_CR8","unstructured":"ANSI. American National Standard for the Safe Use of Lasers. Orlando, FL: Laser Institute of America; 2000."},{"key":"1287_CR9","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1364\/JOSAA.24.001250","volume":"24","author":"FC Delori","year":"2007","unstructured":"Delori FC, Webb RH, Sliney DH, American National Standards I. Maximum permissible exposures for ocular safety (ANSI 2000), with emphasis on ophthalmic devices. J Opt Soc Am A Opt Image Sci Vis. 2007;24:1250\u201365.","journal-title":"J Opt Soc Am A Opt Image Sci Vis"},{"key":"1287_CR10","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1167\/iovs.18-23886","volume":"59","author":"L Sauer","year":"2018","unstructured":"Sauer L, Andersen KM, Li B, Gensure RH, Hammer M, Bernstein PS. Fluorescence lifetime imaging ophthalmoscopy (FLIO) of macular pigment. Investig Ophthalmol Vis Sci. 2018;59:3094\u2013103.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1287_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/tvst.9.9.2","volume":"9","author":"L Sauer","year":"2020","unstructured":"Sauer L, Vitale AS, Milliken CM, Modersitzki NK, Blount D, Bernstein PS. Autofluorescence lifetimes measured with fluorescence lifetime imaging ophthalmoscopy (FLIO) are affected by age, but not by pigmentation or gender. Transl Vis Sci Technol. 2020;9:2.","journal-title":"Transl Vis Sci Technol"},{"key":"1287_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3109\/02713683.2013.779723","volume":"38","author":"M Klemm","year":"2013","unstructured":"Klemm M, Dietzel A, Haueisen J, Nagel E, Hammer M, Schweitzer D. Repeatability of autofluorescence lifetime imaging at the human fundus in healthy volunteers. Curr Eye Res. 2013;38:793\u2013801.","journal-title":"Curr Eye Res"},{"key":"1287_CR13","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1167\/iovs.13-13627","volume":"55","author":"C Dysli","year":"2014","unstructured":"Dysli C, Quellec G, Abegg M, Menke MN, Wolf-Schnurrbusch U, Kowal J, et al. Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects. Investig Ophthalmol Vis Sci. 2014;55:2106\u201313.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1287_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/tvst.8.3.15","volume":"8","author":"S Kwon","year":"2019","unstructured":"Kwon S, Borrelli E, Fan W, Ebraheem A, Marion KM, Sadda SR. Repeatability of fluorescence lifetime imaging ophthalmoscopy in normal subjects with mydriasis. Transl Vis Sci Technol. 2019;8:15.","journal-title":"Transl Vis Sci Technol"},{"key":"1287_CR15","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1364\/BOE.10.001446","volume":"10","author":"M Klemm","year":"2019","unstructured":"Klemm M, Sauer L, Klee S, Link D, Peters S, Hammer M, et al. Bleaching effects and fluorescence lifetime imaging ophthalmoscopy. Biomed Opt Express. 2019;10:1446\u201361.","journal-title":"Biomed Opt Express"},{"key":"1287_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00417-007-0639-9","volume":"246","author":"M Hammer","year":"2008","unstructured":"Hammer M, Konigsdorffer E, Liebermann C, Framme C, Schuch G, Schweitzer D, et al. Ocular fundus auto-fluorescence observations at different wavelengths in patients with age-related macular degeneration and diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2008;246:105\u201314.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1287_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/aos.13269","volume":"95","author":"L Sauer","year":"2017","unstructured":"Sauer L, Peters S, Schmidt J, Schweitzer D, Klemm M, Ramm L, et al. Monitoring macular pigment changes in macular holes using fluorescence lifetime imaging ophthalmoscopy. Acta Ophthalmol. 2017;95:481\u201392.","journal-title":"Acta Ophthalmol"},{"key":"1287_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1364\/OL.26.000202","volume":"26","author":"IV Ermakov","year":"2001","unstructured":"Ermakov IV, McClane RW, Gellermann W, Bernstein PS. Resonant Raman detection of macular pigment levels in the living human retina. Opt Lett. 2001;26:202\u20134.","journal-title":"Opt Lett"},{"key":"1287_CR19","doi-asserted-by":"crossref","unstructured":"Jaggi DSY, Dysli C, Wolf S, Zinkernagel M. Fluorescence lifetime imaging ophthalmoscopy and the influence of oral lutein supplementation on macular pigment: a preliminary study report. Paris: EURetina; 2019.","DOI":"10.1007\/978-3-030-22878-1_5"},{"key":"1287_CR20","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.1167\/iovs.13-12445","volume":"54","author":"JP Greenberg","year":"2013","unstructured":"Greenberg JP, Duncker T, Woods RL, Smith RT, Sparrow JR, Delori FC. Quantitative fundus autofluorescence in healthy eyes. Investig Ophthalmol Vis Sci. 2013;54:5684\u201393.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1287_CR21","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/archopht.122.7.1019","volume":"122","author":"DS Friedman","year":"2004","unstructured":"Friedman DS, O\u2019Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564\u201372.","journal-title":"Arch Ophthalmol"},{"key":"1287_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/07853890600946724","volume":"38","author":"KM Gehrs","year":"2006","unstructured":"Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann Med. 2006;38:450\u201371.","journal-title":"Ann Med"},{"key":"1287_CR23","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1001\/archophthalmol.2010.92","volume":"128","author":"R Klein","year":"2010","unstructured":"Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Nieto FJ, Huang GH, et al. The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol. 2010;128:750\u20138.","journal-title":"Arch Ophthalmol"},{"key":"1287_CR24","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris 3rd","year":"2013","unstructured":"Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844\u201351.","journal-title":"Ophthalmology."},{"key":"1287_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1001\/jamaophthalmol.2013.7376","volume":"132","author":"EY Chew","year":"2014","unstructured":"Age-Related Eye Disease Study 2 Research Group, Chew EY, Clemons TE, Sangiovanni JP, et al. Secondary analyses of the effects of lutein\/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol. 2014;132:142\u20139.","journal-title":"JAMA Ophthalmol"},{"key":"1287_CR26","doi-asserted-by":"publisher","first-page":"AMD65","DOI":"10.1167\/iovs.17-23764","volume":"59","author":"L Sauer","year":"2018","unstructured":"Sauer L, Gensure RH, Andersen KM, Kreilkamp L, Hageman GS, Hammer M, et al. Patterns of fundus autofluorescence lifetimes in eyes of individuals with nonexudative age-related macular degeneration. Investig Ophthalmol Vis Sci. 2018;59:AMD65\u201377.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1287_CR27","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1167\/iovs.17-22184","volume":"58","author":"C Dysli","year":"2017","unstructured":"Dysli C, Fink R, Wolf S, Zinkernagel MS. Fluorescence lifetimes of drusen in age-related macular degeneration. Investig Ophthalmol Vis Sci. 2017;58:4856\u201362.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1287_CR28","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1167\/iovs.15-18381","volume":"57","author":"C Dysli","year":"2016","unstructured":"Dysli C, Wolf S, Zinkernagel MS. Autofluorescence lifetimes in geographic atrophy in patients with age-related macular degeneration. Investig Ophthalmol Vis Sci. 2016;57:2479\u201387.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1287_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/aos.13587","volume":"96","author":"L Sauer","year":"2018","unstructured":"Sauer L, Klemm M, Peters S, Schweitzer D, Schmidt J, Kreilkamp L, et al. Monitoring foveal sparing in geographic atrophy with fluorescence lifetime imaging ophthalmoscopy\u2014a novel approach. Acta Ophthalmol. 2018;96:257\u201366.","journal-title":"Acta Ophthalmol"},{"key":"1287_CR30","first-page":"28","volume":"5","author":"GS Hageman","year":"1999","unstructured":"Hageman GS, Mullins RF. Molecular composition of drusen as related to substructural phenotype. Mol Vis. 1999;5:28.","journal-title":"Mol Vis"},{"key":"1287_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3109\/08820538.2011.570850","volume":"26","author":"K Pepple","year":"2011","unstructured":"Pepple K, Mruthyunjaya P. Retinal pigment epithelial detachments in age-related macular degeneration: classification and therapeutic options. Semin Ophthalmol. 2011;26:198\u2013208.","journal-title":"Semin Ophthalmol"},{"key":"1287_CR32","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1167\/iovs.19-26835","volume":"60","author":"L Sauer","year":"2019","unstructured":"Sauer L, Komanski CB, Vitale AS, Hansen ED, Bernstein PS. Fluorescence lifetime imaging ophthalmoscopy (FLIO) in eyes with pigment epithelial detachments due to age-related macular degeneration. Investig Ophthalmol Vis Sci. 2019;60:3054\u201363.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1287_CR33","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1167\/iovs.11-8970","volume":"53","author":"D Schweitzer","year":"2012","unstructured":"Schweitzer D, Gaillard ER, Dillon J, Mullins RF, Russell S, Hoffmann B, et al. Time-resolved autofluorescence imaging of human donor retina tissue from donors with significant extramacular drusen. Investig Ophthalmol Vis Sci. 2012;53:3376\u201386.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1287_CR34","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s00347-009-1975-4","volume":"106","author":"D Schweitzer","year":"2009","unstructured":"Schweitzer D, Quick S, Schenke S, Klemm M, Gehlert S, Hammer M, et al. Comparison of parameters of time-resolved autofluorescence between healthy subjects and patients suffering from early AMD. Ophthalmologe. 2009;106:714\u201322.","journal-title":"Ophthalmologe"},{"key":"1287_CR35","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4239\/wjd.v6.i2.312","volume":"6","author":"JH Eisma","year":"2015","unstructured":"Eisma JH, Dulle JE, Fort PE. Current knowledge on diabetic retinopathy from human donor tissues. World J Diabetes. 2015;6:312\u201320.","journal-title":"World J Diabetes"},{"key":"1287_CR36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.preteyeres.2015.04.003","volume":"48","author":"R Simo","year":"2015","unstructured":"Simo R, Hernandez C. Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retin Eye Res. 2015;48:160\u201380.","journal-title":"Prog Retin Eye Res"},{"key":"1287_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/2045-3701-4-27","volume":"4","author":"X Zhang","year":"2014","unstructured":"Zhang X, Zeng H, Bao S, Wang N, Gillies MC. Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci. 2014;4:27.","journal-title":"Cell Biosci"},{"key":"1287_CR38","doi-asserted-by":"publisher","first-page":"7989180","DOI":"10.1155\/2017\/7989180","volume":"2017","author":"A Guerin-Dubourg","year":"2017","unstructured":"Guerin-Dubourg A, Cournot M, Planesse C, Debussche X, Meilhac O, Rondeau P, et al. Association between fluorescent advanced glycation end-products and vascular complications in type 2 diabetic patients. Biomed Res Int. 2017;2017:7989180.","journal-title":"Biomed Res Int"},{"key":"1287_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/aos.13174","volume":"95","author":"J Schmidt","year":"2017","unstructured":"Schmidt J, Peters S, Sauer L, Schweitzer D, Klemm M, Augsten R, et al. Fundus autofluorescence lifetimes are increased in non-proliferative diabetic retinopathy. Acta Ophthalmol. 2017;95:33\u201340.","journal-title":"Acta Ophthalmol"},{"key":"1287_CR40","doi-asserted-by":"publisher","first-page":"61106","DOI":"10.1117\/1.JBO.20.6.061106","volume":"20","author":"D Schweitzer","year":"2015","unstructured":"Schweitzer D, Deutsch L, Klemm M, Jentsch S, Hammer M, Peters S, et al. Fluorescence lifetime imaging ophthalmoscopy in type 2 diabetic patients who have no signs of diabetic retinopathy. J Biomed Opt. 2015;20:61106.","journal-title":"J Biomed Opt"},{"key":"1287_CR41","doi-asserted-by":"crossref","unstructured":"Schweitzer D. Metabolic mapping. In: Holz F, Spaide R, editors. Medical retina. Essentials in ophthalmology. Berlin: Springer Berlin Heidelberg; 2010. p. 107\u201323.","DOI":"10.1007\/978-3-540-85540-8_10"},{"key":"1287_CR42","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00347-010-2195-7","volume":"107","author":"D Schweitzer","year":"2010","unstructured":"Schweitzer D, Quick S, Klemm M, Hammer M, Jentsch S, Dawczynski J. Time-resolved autofluorescence in retinal vascular occlusions. Ophthalmologe. 2010;107:1145\u201352.","journal-title":"Ophthalmologe"},{"key":"1287_CR43","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1364\/BOE.9.003078","volume":"9","author":"M Hammer","year":"2018","unstructured":"Hammer M, Sauer L, Klemm M, Peters S, Schultz R, Haueisen J. Fundus autofluorescence beyond lipofuscin: lesson learned from ex vivo fluorescence lifetime imaging in porcine eyes. Biomed Opt Express. 2018;9:3078\u201391.","journal-title":"Biomed Opt Express"},{"key":"1287_CR44","doi-asserted-by":"publisher","first-page":"7290.2008.00025","DOI":"10.2310\/7290.2008.00025","volume":"7","author":"A Abulrob","year":"2008","unstructured":"Abulrob A, Brunette E, Slinn J, Baumann E, Stanimirovic D. Dynamic analysis of the blood-brain barrier disruption in experimental stroke using time domain in vivo fluorescence imaging. Mol Imaging. 2008;7:7290.2008.00025.","journal-title":"Mol Imaging"},{"key":"1287_CR45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/archopht.1968.00980050245019","volume":"80","author":"DI Hamasaki","year":"1968","unstructured":"Hamasaki DI, Kroll AJ. Experimental central retinal artery occlusion: an electrophysiological study. Arch Ophthalmol. 1968;80:243\u20138.","journal-title":"Arch Ophthalmol"},{"key":"1287_CR46","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.2147\/OPTH.S220845","volume":"13","author":"F Semeraro","year":"2019","unstructured":"Semeraro F, Morescalchi F, Russo A, Gambicorti E, Pilotto A, Parmeggiani F, et al. Central serous chorioretinopathy: pathogenesis and management. Clin Ophthalmol. 2019;13:2341\u201352.","journal-title":"Clin Ophthalmol"},{"key":"1287_CR47","first-page":"8890404","volume":"2020","author":"PG Iyer","year":"2020","unstructured":"Iyer PG, Schwartz SG, Russell JF, Flynn HW. Central serous chorioretinopathy: multimodal imaging and management options. Case Rep Ophthalmol. 2020;2020:8890404.","journal-title":"Case Rep Ophthalmol"},{"key":"1287_CR48","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1097\/IAE.0000000000001452","volume":"37","author":"C Dysli","year":"2017","unstructured":"Dysli C, Berger L, Wolf S, Zinkernagel MS. Fundus autofluorescence lifetimes and central serous chorioretinopathy. Retina. 2017;37:2151\u201361.","journal-title":"Retina"},{"key":"1287_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.preteyeres.2012.11.002","volume":"34","author":"P Charbel Issa","year":"2013","unstructured":"Charbel Issa P, Gillies MC, Chew EY, Bird AC, Heeren TF, Peto T, et al. Macular telangiectasia type 2. Prog Retin Eye Res. 2013;34:49\u201377.","journal-title":"Prog Retin Eye Res"},{"key":"1287_CR50","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ajo.2014.12.013","volume":"159","author":"EY Chew","year":"2015","unstructured":"Chew EY, Clemons TE, Peto T, Sallo FB, Ingerman A, Tao W, et al. Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial. Am J Ophthalmol. 2015;159:659\u201366 e1.","journal-title":"Am J Ophthalmol"},{"key":"1287_CR51","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1056\/NEJMoa1815111","volume":"381","author":"ML Gantner","year":"2019","unstructured":"Gantner ML, Eade K, Wallace M, Handzlik MK, Fallon R, Trombley J, et al. Serine and lipid metabolism in macular disease and peripheral neuropathy. N Engl J Med. 2019;381:1422\u201333.","journal-title":"N Engl J Med"},{"key":"1287_CR52","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.oret.2017.10.008","volume":"2","author":"L Sauer","year":"2018","unstructured":"Sauer L, Gensure RH, Hammer M, Bernstein PS. Fluorescence lifetime imaging ophthalmoscopy: a novel way to assess macular telangiectasia type 2. Ophthalmol Retina 2018;2:587\u201398.","journal-title":"Ophthalmol Retina"},{"key":"1287_CR53","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/IAE.0000000000002646","volume":"40","author":"L Sauer","year":"2020","unstructured":"Sauer L, Vitale AS, Andersen KM, Hart B, Bernstein PS. Fluorescence lifetime imaging ophthalmoscopy (FLIO) patterns in clinically unaffected children of macular telangiectasia type 2 (MacTel) patients. Retina. 2020;40:695\u2013704.","journal-title":"Retina."},{"key":"1287_CR54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/IAE.0000000000002411","volume":"40","author":"Y Solberg","year":"2020","unstructured":"Solberg Y, Dysli C, Wolf S, Zinkernagel MS. Fluorescence lifetime patterns in macular telangiectasia type 2. Retina. 2020;40:99\u2013108.","journal-title":"Retina."},{"key":"1287_CR55","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/jmg.40.9.641","volume":"40","author":"M Michaelides","year":"2003","unstructured":"Michaelides M, Hunt DM, Moore AT. The genetics of inherited macular dystrophies. J Med Genet. 2003;40:641\u201350.","journal-title":"J Med Genet"},{"key":"1287_CR56","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.ophtha.2017.04.008","volume":"124","author":"EM Stone","year":"2017","unstructured":"Stone EM, Andorf JL, Whitmore SS, DeLuca AP, Giacalone JC, Streb LM, et al. Clinically focused molecular investigation of 1000 consecutive families with inherited retinal disease. Ophthalmology. 2017;124:1314\u201331.","journal-title":"Ophthalmology."},{"key":"1287_CR57","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/ng0397-236","volume":"15","author":"R Allikmets","year":"1997","unstructured":"Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;15:236\u201346.","journal-title":"Nat Genet"},{"key":"1287_CR58","doi-asserted-by":"publisher","first-page":"22276","DOI":"10.1074\/jbc.M111.329235","volume":"287","author":"NP Boyer","year":"2012","unstructured":"Boyer NP, Higbee D, Currin MB, Blakeley LR, Chen C, Ablonczy Z, et al. Lipofuscin and N-retinylidene-N-retinylethanolamine (A2E) accumulate in retinal pigment epithelium in absence of light exposure: their origin is 11-cis-retinal. J Biol Chem. 2012;287:22276\u201386.","journal-title":"J Biol Chem"},{"key":"1287_CR59","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1093\/hmg\/ddv073","volume":"24","author":"N Zhang","year":"2015","unstructured":"Zhang N, Tsybovsky Y, Kolesnikov AV, Rozanowska M, Swider M, Schwartz SB, et al. Protein misfolding and the pathogenesis of ABCA4-associated retinal degenerations. Hum Mol Genet. 2015;24:3220\u201337.","journal-title":"Hum Mol Genet"},{"key":"1287_CR60","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/hmg\/ddh048","volume":"13","author":"AV Cideciyan","year":"2004","unstructured":"Cideciyan AV, Aleman TS, Swider M, Schwartz SB, Steinberg JD, Brucker AJ, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004;13:525\u201334.","journal-title":"Hum Mol Genet"},{"key":"1287_CR61","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1167\/iovs.15-18033","volume":"57","author":"C Dysli","year":"2016","unstructured":"Dysli C, Wolf S, Hatz K, Zinkernagel MS. Fluorescence lifetime imaging in Stargardt disease: potential marker for disease progression. Investig Ophthalmol Vis Sci. 2016;57:832\u201341.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1287_CR62","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/IAE.0000000000002519","volume":"39","author":"Y Solberg","year":"2019","unstructured":"Solberg Y, Dysli C, Escher P, Berger L, Wolf S, Zinkernagel MS. Retinal flecks in Stargardt disease reveal characteristic fluorescence lifetime transition over time. Retina. 2019;39:879\u201388.","journal-title":"Retina."},{"key":"1287_CR63","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-1-4614-0631-0_11","volume":"723","author":"Z Ablonczy","year":"2012","unstructured":"Ablonczy Z, Gutierrez DB, Grey AC, Schey KL, Crouch RK. Molecule-specific imaging and quantitation of A2E in the RPE. Adv Exp Med Biol. 2012;723:75\u201381.","journal-title":"Adv Exp Med Biol"},{"key":"1287_CR64","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/tvst.6.5.6","volume":"6","author":"AE Sears","year":"2017","unstructured":"Sears AE, Bernstein PS, Cideciyan AV, Hoyng C, Charbel Issa P, Palczewski K, et al. Towards treatment of Stargardt disease: workshop organized and sponsored by the foundation fighting blindness. Transl Vis Sci Technol. 2017;6:6.","journal-title":"Transl Vis Sci Technol"},{"key":"1287_CR65","doi-asserted-by":"crossref","first-page":"251584141881749","DOI":"10.1177\/2515841418817490","volume":"10","author":"A Mitsios","year":"2018","unstructured":"Mitsios A, Dubis AM, Moosajee M. Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments. Ther Adv Ophthalmol. 2018;10:2515841418817490.","journal-title":"Ther Adv Ophthalmol"},{"key":"1287_CR66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1167\/tvst.9.10.33","volume":"9","author":"AS Vitale","year":"2020","unstructured":"Vitale AS, Sauer L, Modersitzki NK, Bernstein PS. Fluorescence lifetime imaging ophthalmoscopy (FLIO) in patients with choroideremia. Transl Vis Sci Technol 2020;9:33.","journal-title":"Transl Vis Sci Technol"},{"key":"1287_CR67","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0039-6257(88)90085-9","volume":"33","author":"RA Pagon","year":"1988","unstructured":"Pagon RA. Retinitis pigmentosa. Surv Ophthalmol. 1988;33:137\u201377.","journal-title":"Surv Ophthalmol"},{"key":"1287_CR68","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1167\/iovs.17-23336","volume":"59","author":"C Dysli","year":"2018","unstructured":"Dysli C, Schurch K, Pascal E, Wolf S, Zinkernagel MS. Fundus autofluorescence lifetime patterns in retinitis pigmentosa. Investig Ophthalmol Vis Sci. 2018;59:1769\u201378.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1287_CR69","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1167\/tvst.7.3.20","volume":"7","author":"KM Andersen","year":"2018","unstructured":"Andersen KM, Sauer L, Gensure RH, Hammer M, Bernstein PS. Characterization of retinitis pigmentosa using fluorescence lifetime imaging ophthalmoscopy (FLIO). Transl Vis Sci Technol. 2018;7:20.","journal-title":"Transl Vis Sci Technol"},{"key":"1287_CR70","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1097\/IAE.0b013e31829232fd","volume":"33","author":"TL Jackson","year":"2013","unstructured":"Jackson TL, Nicod E, Simpson A, Angelis A, Grimaccia F, Kanavos P. Symptomatic vitreomacular adhesion. Retina. 2013;33:1503\u201311.","journal-title":"Retina."},{"key":"1287_CR71","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1097\/IAE.0000000000002718","volume":"40","author":"D Jaggi","year":"2020","unstructured":"Jaggi D, Solberg Y, Dysli C, Ebneter A, Wolf S, Zinkernagel MS. Fluorescence lifetime imaging ophthalmoscopy: findings after surgical reattachment of macula-off rhegmatogenous retinal detachment. Retina. 2020;40:1929\u201337.","journal-title":"Retina"},{"key":"1287_CR72","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1365-2125.1989.tb03439.x","volume":"27","author":"SE Tett","year":"1989","unstructured":"Tett SE, Cutler DJ, Day RO, Brown KF. Bioavailability of hydroxychloroquine tablets in healthy volunteers. Br J Clin Pharmacol. 1989;27:771\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"1287_CR73","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1167\/iovs.14-16345","volume":"56","author":"L de Sisternes","year":"2015","unstructured":"de Sisternes L, Hu J, Rubin DL, Marmor MF. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea. Investig Ophthalmol Vis Sci. 2015;56:3415\u201326.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1287_CR74","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","volume":"123","author":"MF Marmor","year":"2016","unstructured":"Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF.American Academy of Ophthalmology Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). Ophthalmology. 2016;123:1386\u201394.","journal-title":"Ophthalmology"},{"key":"1287_CR75","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41584-018-0111-8","volume":"14","author":"A Jorge","year":"2018","unstructured":"Jorge A, Ung C, Young LH, Melles RB, Choi HK. Hydroxychloroquine retinopathy\u2014implications of research advances for rheumatology care. Nat Rev Rheumatol. 2018;14:693\u2013703.","journal-title":"Nat Rev Rheumatol"},{"key":"1287_CR76","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.oret.2019.04.025","volume":"3","author":"LC Sauer","year":"2019","unstructured":"Sauer LC, Calvo CM, Vitale, AS, Henrie, N, Milliken, CM, Bernstein, PS. Imaging of hydroxychloroquine toxicity with fluorescence lifetime imaging ophthalmoscopy (FLIO). Ophthalmol Retina. 2019;3:814\u201325.","journal-title":"Ophthalmol Retina"},{"key":"1287_CR77","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1167\/iovs.18-26079","volume":"60","author":"Y Solberg","year":"2019","unstructured":"Solberg Y, Dysli C, Moller B, Wolf S, Zinkernagel MS. Fluorescence lifetimes in patients with hydroxychloroquine retinopathy. Investig Ophthalmol Vis Sci. 2019;60:2165\u201372.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1287_CR78","doi-asserted-by":"publisher","first-page":"40375","DOI":"10.1038\/srep40375","volume":"7","author":"A Gakamsky","year":"2017","unstructured":"Gakamsky A, Duncan RR, Howarth NM, Dhillon B, ButtenschN KK, Daly DJ, et al. Tryptophan and non-tryptophan fluorescence of the eye lens proteins provides diagnostics of cataract at the molecular level. Sci Rep. 2017;7:40375.","journal-title":"Sci Rep"},{"key":"1287_CR79","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.9.8.13","volume":"9","author":"JL Brauer","year":"2020","unstructured":"Brauer JL, Schultz R, Klemm M, Hammer M. Influence of lens fluorescence on fluorescence lifetime imaging ophthalmoscopy (FLIO) fundus imaging and strategies for its compensation. Transl Vis Sci Technol. 2020;9:13.","journal-title":"Transl Vis Sci Technol"},{"key":"1287_CR80","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1364\/BOE.7.003198","volume":"7","author":"M Klemm","year":"2016","unstructured":"Klemm M, Blum J, Link D, Hammer M, Haueisen J, Schweitzer D. Combination of confocal principle and aperture stop separation improves suppression of crystalline lens fluorescence in an eye model. Biomed Opt Express. 2016;7:3198\u2013210.","journal-title":"Biomed Opt Express"},{"key":"1287_CR81","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1515\/BMT.2005.038","volume":"50","author":"D Schweitzer","year":"2005","unstructured":"Schweitzer D, Hammer M, Schweitzer F. Limits of the confocal laser-scanning technique in measurements of time-resolved autofluorescence of the ocular fundus. Biomed Tech. 2005;50:263\u20137.","journal-title":"Biomed Tech"},{"key":"1287_CR82","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s00417-014-2813-1","volume":"252","author":"L Ramm","year":"2014","unstructured":"Ramm L, Jentsch S, Augsten R, Hammer M. Fluorescence lifetime imaging ophthalmoscopy in glaucoma. Graefe\u2019s Arch Clin Exp Ophthalmol. 2014;252:2025\u20136.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"1287_CR83","doi-asserted-by":"crossref","unstructured":"Weller J, Budson A. Current understanding of Alzheimer\u2019s disease diagnosis and treatment. F1000Res. 2018;7:F1000 Faculty Rev-1161.","DOI":"10.12688\/f1000research.14506.1"},{"key":"1287_CR84","doi-asserted-by":"publisher","first-page":"e581","DOI":"10.1111\/aos.12374","volume":"92","author":"MP Bambo","year":"2014","unstructured":"Bambo MP, Garcia-Martin E, Pinilla J, Herrero R, Satue M, Otin S, et al. Detection of retinal nerve fiber layer degeneration in patients with Alzheimer\u2019s disease using optical coherence tomography: searching new biomarkers. Acta Ophthalmol. 2014;92:e581\u20132.","journal-title":"Acta Ophthalmol"},{"key":"1287_CR85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fneur.2016.00055","volume":"7","author":"FZ Javaid","year":"2016","unstructured":"Javaid FZ, Brenton J, Guo L, Cordeiro MF. Visual and ocular manifestations of Alzheimer\u2019s disease and their use as biomarkers for diagnosis and progression. Front Neurol. 2016;7:55.","journal-title":"Front Neurol"},{"key":"1287_CR86","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1111\/aos.12609","volume":"93","author":"S Jentsch","year":"2015","unstructured":"Jentsch S, Schweitzer D, Schmidtke KU, Peters S, Dawczynski J, B\u00e4r KJ, et al. Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer\u2019s disease. Acta Ophthalmol. 2015;93:e241\u20137.","journal-title":"Acta Ophthalmol"},{"key":"1287_CR87","unstructured":"Kwon S, Fang W, Borreli E, Ebraheem A, Marion K, Katayama Y, et al. Fluorescence lifetime imaging ophthalmoscopy in early Alzheimer\u2019s disease. Honolulu, Hawaii, USA: ARVO Annual Meeting; 2018."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-01287-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-01287-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-01287-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:10:06Z","timestamp":1684617006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01287-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,2]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1287"],"URL":"https:\/\/doi.org\/10.1038\/s41433-020-01287-y","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,2]]},"assertion":[{"value":"14 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"LS, ASV, PSB: medical consultants for Tesseract Health, Inc. All: The FLIO device was provided by Heidelberg Engineering at no cost. No financial support was received from Heidelberg Engineering.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}